213 related articles for article (PubMed ID: 17070800)
1. Conditional inactivation of Brca1 in the mouse ovarian surface epithelium results in an increase in preneoplastic changes.
Clark-Knowles KV; Garson K; Jonkers J; Vanderhyden BC
Exp Cell Res; 2007 Jan; 313(1):133-45. PubMed ID: 17070800
[TBL] [Abstract][Full Text] [Related]
2. Conditional inactivation of Brca1, p53 and Rb in mouse ovaries results in the development of leiomyosarcomas.
Clark-Knowles KV; Senterman MK; Collins O; Vanderhyden BC
PLoS One; 2009 Dec; 4(12):e8534. PubMed ID: 20046869
[TBL] [Abstract][Full Text] [Related]
3. Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies.
Roland IH; Yang WL; Yang DH; Daly MB; Ozols RF; Hamilton TC; Lynch HT; Godwin AK; Xu XX
Cancer; 2003 Dec; 98(12):2607-23. PubMed ID: 14669280
[TBL] [Abstract][Full Text] [Related]
4. Profiling of protein kinases in the neoplastic transformation of human ovarian surface epithelium.
Wong AS; Kim SO; Leung PC; Auersperg N; Pelech SL
Gynecol Oncol; 2001 Aug; 82(2):305-11. PubMed ID: 11531284
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of a preneoplastic phenotype in ovarian surface epithelial cells derived from prophylactic oophorectomies.
He QY; Zhou Y; Wong E; Ehlen TG; Auersperg N; Chiu JF; Wong AS
Gynecol Oncol; 2005 Jul; 98(1):68-76. PubMed ID: 15913737
[TBL] [Abstract][Full Text] [Related]
6. BRCA1 and p53 protein expression in cultured ovarian surface epithelial cells derived from women with and without a BRCA1 germline mutation.
Piek JM; Dorsman JC; Massuger LF; Ansink AC; Weegenaar J; Shvarts A; Kenemans P; Verheijen RH
Arch Gynecol Obstet; 2006 Oct; 274(6):327-31. PubMed ID: 16826413
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic transformation of human ovarian surface epithelial cells with defined cellular oncogenes.
Sasaki R; Narisawa-Saito M; Yugawa T; Fujita M; Tashiro H; Katabuchi H; Kiyono T
Carcinogenesis; 2009 Mar; 30(3):423-31. PubMed ID: 19126650
[TBL] [Abstract][Full Text] [Related]
8. Expression of cell cycle regulatory proteins in ovaries prophylactically removed from Jewish Ashkenazi BRCA1 and BRCA2 mutation carriers: correlation with histopathology.
Kerner R; Sabo E; Gershoni-Baruch R; Beck D; Ben-Izhak O
Gynecol Oncol; 2005 Nov; 99(2):367-75. PubMed ID: 16051332
[TBL] [Abstract][Full Text] [Related]
9. A mouse model for the molecular characterization of brca1-associated ovarian carcinoma.
Xing D; Orsulic S
Cancer Res; 2006 Sep; 66(18):8949-53. PubMed ID: 16982732
[TBL] [Abstract][Full Text] [Related]
10. Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium.
Flesken-Nikitin A; Choi KC; Eng JP; Shmidt EN; Nikitin AY
Cancer Res; 2003 Jul; 63(13):3459-63. PubMed ID: 12839925
[TBL] [Abstract][Full Text] [Related]
11. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.
Piek JM; van Diest PJ; Zweemer RP; Jansen JW; Poort-Keesom RJ; Menko FH; Gille JJ; Jongsma AP; Pals G; Kenemans P; Verheijen RH
J Pathol; 2001 Nov; 195(4):451-6. PubMed ID: 11745677
[TBL] [Abstract][Full Text] [Related]
12. Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes.
Barakat RR; Federici MG; Saigo PE; Robson ME; Offit K; Boyd J
Cancer; 2000 Jul; 89(2):383-90. PubMed ID: 10918170
[TBL] [Abstract][Full Text] [Related]
13. Cell-nonautonomous induction of ovarian and uterine serous cystadenomas in mice lacking a functional Brca1 in ovarian granulosa cells.
Chodankar R; Kwang S; Sangiorgi F; Hong H; Yen HY; Deng C; Pike MC; Shuler CF; Maxson R; Dubeau L
Curr Biol; 2005 Mar; 15(6):561-5. PubMed ID: 15797026
[TBL] [Abstract][Full Text] [Related]
14. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.
Xu X; Qiao W; Linke SP; Cao L; Li WM; Furth PA; Harris CC; Deng CX
Nat Genet; 2001 Jul; 28(3):266-71. PubMed ID: 11431698
[TBL] [Abstract][Full Text] [Related]
15. Induction of proliferation in the primate ovarian surface epithelium in vivo.
Wright JW; Pejovic T; Fanton J; Stouffer RL
Hum Reprod; 2008 Jan; 23(1):129-38. PubMed ID: 18000169
[TBL] [Abstract][Full Text] [Related]
16. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
17. Antisense inhibition of BRCA1 expression and molecular analysis of hereditary tumors indicate that functional inactivation of the p53 DNA damage response pathway is required for BRCA-associated tumorigenesis.
Reedy MB; Hang T; Gallion H; Arnold S; Smith SA
Gynecol Oncol; 2001 Jun; 81(3):441-6. PubMed ID: 11371136
[TBL] [Abstract][Full Text] [Related]
18. Cultures of ovarian surface epithelium from women with and without a hereditary predisposition to develop female adnexal carcinoma.
Piek JM; Dorsman JC; Shvarts A; Ansink AC; Massuger LF; Scholten P; van Diest PJ; Dijkstra JC; Weegenaar J; Kenemans P; Verheijen RH
Gynecol Oncol; 2004 Mar; 92(3):819-26. PubMed ID: 14984947
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic oophorectomy: a morphologic and immunohistochemical study.
Schlosshauer PW; Cohen CJ; Penault-Llorca F; Miranda CR; Bignon YJ; Dauplat J; Deligdisch L
Cancer; 2003 Dec; 98(12):2599-606. PubMed ID: 14669279
[TBL] [Abstract][Full Text] [Related]
20. Early transformative changes in normal ovarian surface epithelium induced by oxidative stress require Akt upregulation, DNA damage and epithelial-stromal interaction.
King SM; Quartuccio SM; Vanderhyden BC; Burdette JE
Carcinogenesis; 2013 May; 34(5):1125-33. PubMed ID: 23299406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
